Related Experiment Video
Updated: Jan 8, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Neuroimmune Crossroads: Pathophysiological Links Between Bipolar Disorder and Inflammatory Bowel Disease
Giuseppe Marano1, Francesca Bardi1, Emanuela De Chiara1
1Unit of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy; Department of Neurosciences, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Bipolar disorder (BD) and inflammatory bowel disease (IBD) frequently co-occur, impacting patient health and treatment. Shared inflammatory pathways and a gut-brain axis link these conditions, necessitating integrated care.
Area of Science:
- Neuroscience
- Gastroenterology
- Immunology
Background:
- Bipolar disorder (BD) and inflammatory bowel disease (IBD) frequently co-occur, presenting complex treatment challenges.
- Shared inflammatory mechanisms are implicated, but the clinical and pathophysiological interplay between BD and IBD is poorly understood.
Purpose of the Study:
- To review the existing literature on the comorbidity of bipolar disorder and inflammatory bowel disease.
- To characterize the clinical, epidemiological, and mechanistic aspects of BD-IBD overlap.
Main Methods:
- A narrative review of peer-reviewed literature from January 2000 to May 2025 was conducted.
- Searches were performed in PubMed, Web of Science, and PsycINFO using terms related to BD, IBD, comorbidity, and inflammatory markers.
- Studies reporting clinical, epidemiological, or mechanistic data on BD-IBD overlap were included after screening.
Main Results:
- BD affects 3-7% of IBD patients, significantly higher than the general population (1-2%).
- Comorbid BD-IBD is linked to increased hospitalizations, severe GI and psychiatric symptoms, and reduced quality of life.
- Complex treatment interactions exist, with potential exacerbation of inflammation by psychiatric medications and mood destabilization by IBD treatments. Dysregulated cytokines, gut-microbiome alterations, and genetic factors are implicated mechanistic pathways.
Conclusions:
- The co-occurrence of BD and IBD highlights a bidirectional gut-brain neuroimmune axis mediated by systemic inflammation.
- Integrated, multidisciplinary care is essential for managing this comorbidity.
- Future research should prioritize longitudinal studies and targeted anti-inflammatory interventions for improved patient outcomes.
Related Concept Videos
Bipolar Disorder
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

